Language

CAS No. 936623-90-4 | LCZ696

Name: LCZ696 CAS No.936623-90-4 MF:C48H58N6O8 MW:847.03 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery

Categories：

Other Life Science Chemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 936623-90-4 | LCZ696

Synonyms:[(C24H29N5O3).(C24H29NO5).2.5(H2O).3Na];

LCZ696ENTRESTOTM;

LCZ696Entresto;

4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate;

SacubitrilmixturewithValsartan;

CocrystalofSacubitrilandValsartan;(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)hexanamido)-3-methylbutanoicacid;

Specification:

ITEMS	SPECIFICATION
CAS	936623-90-4
MF	C48H58N6O8
MW	847.03
Solubility	≥45.05 mg/mL in DMSO; ≥11.28 mg/mL in water; ≥28.5 mg/mL in ethanol
Form	Solid
Storage condition	Store at -20°C

The heart failure drug LCZ696 is a drug developed by Novartis Pharmaceuticals in the United States. Heart failure is a life-threatening debilitating disease. The patient's heart cannot pump enough blood to supply the whole body, and the patient has difficulty breathing, fatigue and Symptoms such as fluid retention may appear slowly and gradually worsen, significantly affecting quality of life.

Package and transportation :

Package: 5g,25g,200g,500g,1kg